AstraZeneca Pharma inks distribution pact with Abbott for diabetes drug By Admin on December 9, 2018 Dapagliflozin, an innovative Type 2 diabetes medicine, is AstraZeneca Pharma’s leading diabetes medicine. Original source: https://health.economictimes.indiatimes.com/news/pharma/astrazeneca-pharma-inks-distribution-pact-with-abbott-for-diabetes-drug/66982577?utm_source=RSS&utm_medium=ETRSS Also Read: Dr Reddy’s to use CMO for vaccine Published in Industry News Health NewsPharma ArticlesPharma News Admin More from Industry NewsMore posts in Industry News »Zydus cuts price of generic remdesivirFrench pharma firm guilty of fraud, manslaughter over weight loss pill: courtEquity indices swing higher, metal and pharma stocks gainFrench pharma giant faces verdict on weight loss pill deaths